TABLE 2.
Study (PMID) | Representativeness of the exposed cohort | Selection of the nonexposed cohort | Ascertainment of exposure | Outcome of interest not present at start of study | Control for important factors | Assessment of outcome | Follow-up period long enough for outcomes to occura | Adequacy of follow-up evaluation of cohortsb | Total quality scores |
---|---|---|---|---|---|---|---|---|---|
33239433 | ★ | ★ | ★ | ★ | ★ | ★ | ★ | 7 | |
33199490 | ★ | ★ | ★ | ★ | ★ | ★ | ★ | 7 | |
32648384 | ★ | ★ | ★ | ★ | ★ | ★ | ★★ | ★ | 9 |
31831026 | ★ | ★ | ★ | ★ | ★ | ★★ | ★ | 8 | |
30864102 | ★ | ★ | ★ | ★ | ★ | ★ | ★ | ★ | 8 |
29349612 | ★ | ★ | ★ | ★ | ★ | ★★ | ★ | 8 | |
27396375 | ★ | ★ | ★ | ★ | ★ | ★ | ★★ | ★ | 9 |
26520780 | ★ | ★ | ★ | ★ | ★ | ★ | ★ | ★ | 8 |
26125449 | ★ | ★ | ★ | ★ | ★ | ★ | ★ | 7 | |
19139429 | ★ | ★ | ★ | ★ | ★ | ★ | ★ | 7 |
A cohort study with a follow-up time longer than 5 years was assigned additional one star.
A cohort study with a follow-up rate greater than 80% was assigned additional one star.